Latest News & Features
Americas
Abbott Laboratories has fended off patent infringement claims filed by Enzo Biochem after convincing a US court that the patents did not describe the invention in a sufficient way. 22 August 2017
Asia-Pacific
Samsung’s biopharmaceutical arm Samsung Bioepis has agreed a deal with Takeda to tackle “unmet disease areas”, marking the South Korean company’s move into the novel drugs market. 22 August 2017
Americas
Johnson & Johnson has been handed another victory in its fight against counterfeits after being granted an injunction preventing several companies from selling “potentially deadly” versions of a blood glucose strip it produces. 21 August 2017
Americas
Procter & Gamble has failed to sue an alleged patent infringer after falling foul of the US Supreme Court’s clarification on appropriate venues for litigation. 21 August 2017
Americas
Mylan has finalised a $465 million payment to the US government to settle a lawsuit about the classification of EpiPen Auto-Injector (epinephrine) under the Medicaid Drug Rebate Program. 18 August 2017
Americas
Two US House Representatives have begun an investigation into the pricing of drugs used to treat multiple sclerosis. 18 August 2017
Americas
Janssen, a subsidiary of Johnson & Johnson, has acquired an anti-depressant drug candidate in a $25 million deal with Cerecor. 17 August 2017
Americas
The Biotechnology Industry Organization and the Pharmaceutical Research and Manufacturers of America, two trade groups representing US pharmaceutical companies, have backed Acorda in an appeal to the US Court of Appeals for the Federal Circuit. 17 August 2017
Americas
US President Donald Trump has put an end to his manufacturing council after a series of resignations. 17 August 2017
Americas
Par Pharmaceutical has sued a pair of former employees who set up a rival company, accusing them of poaching staff to steal trade secrets. 17 August 2017